Although these differences did not reach statistical significance, they may still affect the accuracy of survival analyses and should therefore be interpreted cautiously.
← all excerpts
Liver function dynamics in advanced hepatocellular carcinoma receiving immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization.
1
—
—